BR9710830A - Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. - Google Patents

Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein.

Info

Publication number
BR9710830A
BR9710830A BR9710830-8A BR9710830A BR9710830A BR 9710830 A BR9710830 A BR 9710830A BR 9710830 A BR9710830 A BR 9710830A BR 9710830 A BR9710830 A BR 9710830A
Authority
BR
Brazil
Prior art keywords
begf
recombinant
protein
production
growth factor
Prior art date
Application number
BR9710830-8A
Other languages
Portuguese (pt)
Inventor
Paulo Cesar Peregrino Ferreira
Erna Geessien Kroon
Flavio Guimaraes Da Fonseca
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BR9710830-8A priority Critical patent/BR9710830A/en
Publication of BR9710830A publication Critical patent/BR9710830A/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

<B>Patente de invenção para o ''PROCESSO PARA PRODUçãO DE FATOR DE CRESCIMENTO DO VìRUS BEAN 58058 (BEGF) RECOMBINANTE E DA PROTEìNA DO BEGF RECOMBINANTE'' A presente invenção diz respeito ao processo de produção da proteína fator de crescimento do vírus BeAn 58058 (BEGF) recombinante produzida através de técnicas de engenharia genética e da proteína BEGF recombinante, para ser empregada em uso clínico médico ou veterinário ou em pesquisa. O DNA contendo o gene que codifica a proteína BEGF foi obtido realizando-se as seguintes etapas: Amplificação do DNA, (1), Clonagem (2), Transformação (3) Sequenciamento (4) Produção da proteína (5), Purificação da proteína. (6)<B> Invention patent for the '' PROCESS FOR THE PRODUCTION OF GROWTH FACTOR OF THE RECOMBINANT VIRUS BEAN 58058 (BEGF) AND THE RECOMBINANT BEGF PROTEIN '' The present invention relates to the production process of the BeAn virus growth factor protein 58058 (BEGF) recombinant produced using genetic engineering techniques and recombinant BEGF protein, to be used in clinical medical or veterinary use or in research. The DNA containing the gene encoding the BEGF protein was obtained by performing the following steps: DNA amplification, (1), Cloning (2), Transformation (3) Sequencing (4) Protein production (5), Protein purification . (6)

BR9710830-8A 1997-12-30 1997-12-30 Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein. BR9710830A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9710830-8A BR9710830A (en) 1997-12-30 1997-12-30 Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR9710830-8A BR9710830A (en) 1997-12-30 1997-12-30 Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein.

Publications (1)

Publication Number Publication Date
BR9710830A true BR9710830A (en) 2000-05-23

Family

ID=4068867

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710830-8A BR9710830A (en) 1997-12-30 1997-12-30 Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein.

Country Status (1)

Country Link
BR (1) BR9710830A (en)

Similar Documents

Publication Publication Date Title
BRPI0511118A (en) untranscribed haemophilus influenzae polypeptides
ES2134198T3 (en) MUTATIONS IN THE 5 &#39;TO 3&#39; EXONUCLEASE OF DNA POLYMERASES.
BR9913360A (en) Urate oxidase
ATE192500T1 (en) RECOMBINANT VIRUS VECTORS FOR EXPRESSION IN MUSCLE CELLS
NO973685L (en) Multi-tumor aberrant growth genes
TR200401186T4 (en) Artificial chromosome structures containing nucleic acid sequences capable of directing the formation of a recombinant RNA-virus.
BR9610511A (en) Circularly shaped DNA molecule useful in gene therapy comprising at least one nucleic sequence of interest process for its production recombinant cell pharmaceutical composition use of a DNA molecule and process for the production of a recombinant protein
BR9803960A (en) D-sorbitol dehydrogenase gene.
ATE88500T1 (en) DNA SEQUENCES CODING FOR PROTEINS WITH THE BIOLOGICAL ACTIVITY OF THE HUSI-TYPE INHIBITORS, GENETIC METHODS FOR THE PRODUCTION OF THESE PROTEINS, AND PHARMACEUTICALS CONTAINING THESE PROTEINS.
ATE412736T1 (en) RETROVIRUS FROM THE HIV GROUP AND ITS USE
DE3856240T2 (en) PRODUCTION OF P1 PROTEINS AND VACCINE AGAINST GONORRHEA
DE69736276D1 (en) HUMAN DNASE RESISTANT AGAINST ACTININHIBITORS
DK0771352T3 (en) Non-typeable Haemophilus influenza LKP peak adhesin protein and nucleic acid
BR9710830A (en) Process for production of growth factor of recombinant bean58058 virus (begf) and of recombinant begf protein.
Holtet et al. Receptor‐binding domain of human α2‐macroglobulin Expression, folding and biochemical characterization of a high‐affinity recombinant derivative
PT704527E (en) DNA sequencing that encodes BIOSAETIC INSULIN PRECURSORS AND PROCESS FOR THE PREPARATION OF INSULIN
DE69529750D1 (en) IMPROVEMENTS IN THE PRODUCTION OF PROTEINS IN HOST CELLS
PT1322753E (en) NEW REDUCTIONS OF 2,5-DICETO-L-GLUCONIC ACID AND METHODS OF USE
BR0002493A (en) Process for the preparation of l-amino acids by fermentation and nucleotide sequences encoding the accda gene
DE69031996D1 (en) HUMAN RECOMBINANT PLACENTAL RIBONUCLEASE INHIBITOR AND METHOD FOR THE PRODUCTION THEREOF
Ikeuchi et al. The enhancing of a cysteine proteinase activity at acidic pH by protein engineering, the role of glutamic 50 in the enzyme mechanism of caricain
DE69730967D1 (en) Human dnase ii
WO1999052947A3 (en) TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
BR9710828A (en) Process for the production of recombinant human beta-cis interferon protein and recombinant human beta-cis interferon protein
Dodson Fred Sanger: sequencing pioneer

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15Z Prolongation of time limit refused

Free format text: NEGADA A SOLICITACAO DE DEVOLUCAO DE PRAZO UMA VEZ QUE A MESMA NAO FOI APRESENTADA AO INPI NA VIGENCIA DO PRAZO PREVISTO PARA A PRATICA DO ATO, CONFORME DEFINIDO NO ART. 221 DA LPI. A COPIA DO PARECER (DAS RAZOES) PODERA SER SOLICITADA ATRAVES DO FORMULARIO 1.05. (DESTA DATA CORRE O PRAZO DE 60 (SESSENTA) DIAS PARA EVENTUAL RECURSO DO INTERESSADO).

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B12F Other appeals [chapter 12.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 12A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2207 DE 24/04/2013.